Acute Myeloid Leukemia Therapeutics Market 2027: Demand, Top Leaders, Size, Share and Growth
According to IMARC Group’s latest report “ Acute Myeloid Leukemia Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 .’ the global acute myeloid leukemia therapeutics market size reached US$ 954.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1947.8 Million by 2027, exhibiting a growth rate (CAGR) of 12.8% during 2022-2027. Acute myeloid leukemia (AML) is a cancer of bone marrow and blood with excess immature white blood cells. It is characterized by breathlessness, fatigue, discoloration of the skin, high body temperatures, bleeding gums, weight loss, and nosebleeds. AML occurs when a bone marrow cell suddenly develops mutations in its deoxyribonucleic acid (DNA) or genetic material and its primary treatment includes chemotherapy, targeted drug, hormone, and radiation therapies, and stem cell transplant. Request for a PDF Sample of this Report: https://www.imarcgroup.com/acute...